Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
64
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

Yasushi Fukushima1 Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan
,
Yuji Nakatani2 Department of Internal Medicine, Nakatani Hospital, Hyogo, Japan
,
Yumiko Ide3 Department of Internal Medicine, Tokyo Center Clinic, Tokyo, Japan
,
Hisakuni Sekino4 Department of Internal Medicine, Sekino Hospital, Tokyo, Japan
,
Earl St Rose5 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA
,
Shahid Siddiqui6 AstraZeneca, Gaithersburg, MD, USA
,
Andrea Maes5 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA
&
Colin Reisner5 Pearl – a member of the AstraZeneca Group, Morristown, NJ, USA;6 AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
 show all
Pages 1187-1194 | Published online: 13 Apr 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.